ArticleJournal for immunotherapy of cancer2016
A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma.
Andrew S Brohl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled ittrialcites it